TRACIE GIVENS: Open Payments
NPI 1033459193 · ALEXANDRIA, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,262 in 126 payments from 19 companies in 2025. Trend: 2023 $1,947 · 2024 $2,174 · 2025 $2,262
Food & beverage: $2,262
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 40 | $662 |
| GENZYME CORPORATION | 15 | $323 |
| Axsome Therapeutics, Inc. | 15 | $203 |
| PFIZER INC. | 7 | $146 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $141 |
| Lilly USA, LLC | 6 | $124 |
| Janssen Biotech, Inc. | 6 | $113 |
| UCB, Inc. | 4 | $85 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $62 |
| Corium, LLC | 2 | $59 |
Products named: DUPIXENT, Auvelity, VRAYLAR, RINVOQ, CAPLYTA, QULIPTA, SKYRIZI, TREMFYA.
Industry payments across LA — which companies pay providers there.
